Tap to expand

NUBEQA is a prescription medicine used to treat adults with prostate cancer:

that has spread to other parts of the body and responds to medical or surgical treatment that lowers testosterone (mHSPC), in combination with docetaxel

mHSPC=metastatic hormone-sensitive prostate cancer.
See results in mHSPC 

that has not spread to other parts of the body and no longer responds to medical or surgical treatment that lowers testosterone (nmCRPC)

nmCRPC=non-metastatic castration-resistant prostate cancer.
See results in nmCRPC 

NUBEQA HELPS YOU
LIVE FOR WHAT YOU LOVE

Vintage photo of a man and woman riding a motorcycle.
Recreated photo of a couple on a motorcycle.

NUBEQA EXTENDED OVERALL SURVIVAL BY LOWERING THE RISK OF DEATH

in mHSPC by 32%

when NUBEQA was added to hormone therapy* + docetaxel (chemotherapy) vs hormone therapy + chemotherapy alone

See results in mHSPC

in nmCRPC by 31%

when NUBEQA was added to hormone therapy vs hormone therapy alone

See results in nmCRPC

*Hormone therapy includes drug treatments or surgery to lower testosterone.

The clinical study in nmCRPC was designed to measure metastasis-free survival (MFS) and also overall survival.

In the clinical study for mHSPC

Icon with text of live life longer

NUBEQA extended overall survival (32% reduction in risk of death)   
More men who added NUBEQA to hormone therapy + chemotherapy were still alive at   
4 years vs hormone therapy + chemotherapy alone (63% vs 50%, respectively)

In the clinical study for nmCRPC

Icon with text of men lived 2x longer

without cancer spreading to   
other parts of their body (MFS) when they added NUBEQA to hormone therapy compared with men on hormone therapy alone   
(median 3.4 yrs vs 1.5 yrs)

Median is the middle value in a set of numbers, not the average.

Pronounced

(new-BEH-kah)

Press to hear pronunciation

NUBEQA Patient Brochures

Find out more about what NUBEQA can offer.

Downloadable Nubeqa (darolutamide) mHSPC patient brochure

NUBEQA Side Effects

See possible side effects while taking NUBEQA.

An icon of a male with thunder sign on the top, left and right.

Explore Financial Support

Plus more with Access Services by BayerTM.

NUBEQA® (darolutamide) $0 Co-pay Card

Meet Dick and Jan

Learn about their journey with non-metastatic castration-resistant prostate cancer (nmCRPC) and what NUBEQA has meant to them.

Thumbnail of video of Dick and Jan’s treatment journey using Nubeqa (darolutamide)